Pharma Stocks

Pharmaceutical companies manufacture drugs that are used in medicines to cure illness ranging from cancer to a common cold. India has some of the world's largest pharmaceutical companies who have a strong reputation for mass producing generic drugs.

Innovation and Research Focus

Global Health Impact

Stable Revenue Streams

Regulatory Resilience

Get Started Live Share Market

List of Pharma Stocks

Pharma Stocks More Collections >

The Pharma Stocks collection features companies involved in the research, development, manufacturing, and distribution of pharmaceuticals. This sector is charac...Learn More

More Collections >

Filter

Reset Filter

Price

Market Cap

Last 1 Yr return

Analyst Recommendation

Dividend Yield

Index

Reset Filter

Apply

Name	Price	M Cap	Analyst Rating	Target Price	Alpha	1Y Return	3Y Return	5Y Return	PE	Industry PE	PB	Beta	Div Yld	Net Profit Qtr	Net Profit QoQ %	Net Profit YoY %	Net Profit 3Y Change %	Rev Qtr (in Cr)	Rev QoQ (in %)	Rev 1Y change %	Rev 3Y change %	Profit Mar Qtr	Profit Mar QoQ	Profit Mar 1Y Change%	Profit Mar 3Y Change%	Sector	M Cap	ROE	ROCE	EPS	Volume
Sun Pharmaceuticals Industries Ltd	₹1,485.75	Large Cap	BUY	1569.57	25.56%	51.63%	133.91%	216.32%	40.02	61.41	9.93	0.49	1.17%	2568.03 Cr	6.97%	151.36%	104.47%	12156.86	1.28%	13.53%	33.65%	19.51%	5.61%	121.4%	53%	Basic Materials	356217.27	13.89%	16.26%	35.68	4652802
Cipla Ltd	₹1,398.20	Large Cap	BUY	1452.09	23.07%	49.14%	48.74%	141.11%	29.31	61.41	0	0.2	0.94%	1068.51 Cr	-7.55%	10.78%	83.29%	6505.66	-1.27%	4.55%	32.81%	12.46%	-6.37%	5.97%	38.01%	Basic Materials	108731.88	10.66%	14.76%	35.13	4415444
Divis Laboratories Ltd	₹3,813.80	Large Cap	HOLD	3442.36	-8.03%	18.03%	-0.41%	116.25%	72.32	61.41	5.9	0.67	1.06%	358 Cr	2.87%	-38.41%	32.46%	1855	-2.83%	-13.31%	43.99%	23.47%	5.87%	-28.95%	-8.01%	Basic Materials	100045.82	14.82%	19.27%	68.69	473533
Dr Reddys Laboratories Ltd	₹5,950.80	Large Cap	HOLD	6000.77	-2.22%	23.84%	17.47%	108.16%	18.93	61.41	3.74	0.47	0.87%	1380.9 Cr	-6.83%	106.52%	122.47%	7214.8	4.86%	14.5%	40.83%	18.27%	-11.16%	80.36%	57.97%	Basic Materials	99291.9	13.46%	18.82%	270.55	266985
Zydus Lifesciences Ltd	₹933.50	Large Cap	BUY	838.46	59.53%	85.6%	68.46%	191.14%	32.66	61.41	3.65	0.44	1.22%	733.5 Cr	-5.94%	-56.32%	69.9%	4343.7	2%	14.08%	20.94%	11.59%	-7.78%	-61.71%	40.48%	Basic Materials	96543.12	11.38%	13.31%	19.74	3433272
Mankind Pharma Ltd	₹2,398.30	Large Cap	BUY	2184.17	42.19%	68.25%	68.25%	68.25%	55.5	61.41	0	0.07	NA	459.81 Cr	-10.05%	-9.86%	24.01%	2606.96	-3.73%	12.44%	49.17%	14.97%	-6.56%	-19.83%	-16.87%	Pharmaceuticals	95862.82	17.43%	20.91%	0	569612
Torrent Pharmaceuticals Ltd	₹2,686.45	Large Cap	BUY	2728.41	36.59%	62.66%	110.03%	196.36%	59.74	61.41	8.06	0.3	1.43%	443 Cr	14.77%	60.22%	21.52%	2691	2.4%	13.07%	21.17%	12.94%	12.08%	41.7%	0.29%	Basic Materials	89257.59	16.43%	17.68%	36.79	254562
Lupin Ltd	₹1,580.00	Mid Cap	HOLD	1514.03	99%	125.06%	48.7%	82.82%	40.14	61.41	1.6	0.36	0.62%	618.7 Cr	24.91%	-129.66%	-265.95%	5079.88	2.85%	1.44%	8.24%	2.69%	21.45%	-129.24%	-253.31%	Basic Materials	72010.8	2.33%	3.21%	9.84	1363205
Aurobindo Pharma Ltd	₹1,084.05	Mid Cap	BUY	1185.46	59.34%	85.41%	12.57%	39.21%	23.14	61.41	1.69	0.55	1.45%	939.97 Cr	25.01%	-27.18%	-32.21%	7271.23	1.69%	5.97%	7.61%	7.76%	22.93%	-31.28%	-37%	Basic Materials	64057.74	7.02%	8.39%	32.9	923812
Alkem Laboratories Ltd	₹4,720.95	Mid Cap	HOLD	5184	11.14%	37.2%	68.14%	173.16%	35.75	61.41	4.34	0.63	1.47%	604.28 Cr	-1.73%	-40.08%	-12.4%	3323.87	-3.38%	9.08%	39.01%	8.68%	1.71%	-45.07%	-36.98%	Basic Materials	56248.16	12.54%	12.78%	84.22	55269
Abbott India Ltd	₹25,452.55	Mid Cap	BUY	27670.43	-11.96%	14.1%	70.9%	228.72%	0	61.41	14.72	0.41	NA	0 Cr	0%	16.35%	0%	NA	0%	14.52%	0%	14.18%	0%	1.6%	0%	Basic Materials	54665.84	31.6%	39.94%	35.67	16820
Biocon Ltd	₹289.60	Mid Cap	HOLD	279.11	-1.91%	24.15%	-29.17%	-8.66%	27.9	61.41	2.27	1.09	0.73%	753.3 Cr	336.19%	-16.67%	-26.17%	3953.7	14.19%	36.54%	77.35%	5.75%	281.98%	-38.97%	-58.37%	Basic Materials	33634.81	-0.14%	1.5%	5.36	24779262

Introduction to Pharma Stocks

Pharma Stocks, a sector synonymous with health advancements. These stocks represent pharmaceutical companies, pivotal in delivering medical solutions and innovations.

Why to invest in Pharma Stocks

Research and Development Focus: Pharma stocks are driven by a strong emphasis on research and development for the creation of innovative drugs.
Global Health Impact: Investing in pharma stocks aligns with contributing to global health and addressing medical challenges.
Stable Revenue Streams: These stocks often provide stable revenues due to consistent demand for medications and healthcare solutions.
Regulatory Resilience: Pharma stocks showcase resilience to regulatory changes, contributing to a stable investment environment.
Defensive Characteristics: Considered defensive, pharma stocks can offer stability during economic downturns.

Advantages of investing in Pharma Stocks

Pharma Stocks—an arena marked by innovation, demographic growth, and economic resilience. These investments thrive on breakthroughs, stable revenues, and alignment with global health trends, offering a compelling avenue for long-term growth in a dynamically evolving sector.

Innovation and Breakthroughs
Pharma stocks offer exposure to companies at the forefront of medical innovation, driving breakthrough treatments and advancements.
Demographic Tailwind
With a global aging population, pharma stocks benefit from increased healthcare needs, contributing to sustained demand for medications and healthcare solutions.
Defensive Characteristics
Considered defensive, pharma stocks exhibit stability during economic downturns, showcasing resilience in the face of market fluctuations.
Stable Revenue Streams
Many pharmaceutical companies enjoy stable revenue streams due to ongoing demand for essential medications and healthcare solutions.
Global Health Trends
Investing in pharma stocks aligns with addressing global health challenges, positioning these stocks for sustained long-term growth.
Regulatory Stability
Pharma stocks demonstrate resilience to regulatory changes, providing a stable investment environment for investors seeking predictability in the sector.

Who should consider investing in Pharma Stocks

For long-term stability, risk-averse investing, and a keen interest in innovation, Pharma Stocks present a compelling opportunity. Explore the potential for sustained growth in this dynamic sector, catering to those seeking reliability and advancements in medical research.

Long-Term Investors
Pharma stocks are suitable for long-term investors seeking stability, as the sector often realizes its full potential over extended periods.
Risk-Averse Individuals
Suited for risk-averse investors, pharma stocks exhibit defensive characteristics, providing stability even during market fluctuations.
Investors Interested in Innovation
Appealing to those interested in innovative advancements, pharma stocks provide exposure to companies driving breakthroughs in medical research and development.

Points to consider before investing in Pharma Stocks

As you delve into Pharma Stock investments, strategic considerations are crucial. Assess the regulatory framework, innovation pipeline, financial health, demographic trends, market positioning, and global health issues for informed and prudent decision-making in this dynamic sector.

Regulatory Environment
Assess the regulatory landscape affecting pharma stocks to understand potential impacts on operations and financials.
Pipeline of Innovation
Examine the innovation pipeline of pharma companies, assessing their potential for developing new drugs and medical technologies.
Financial Health
Thoroughly analyze the financial health of healthcare companies, considering factors like revenue growth, profitability, and debt levels.
Demographic Trends:
Consider demographic trends and their influence on healthcare needs, as an aging population often leads to increased demand for medical services.
Competition and Market Position
Evaluate the competitive landscape and market positioning of pharma stocks to identify companies with a strong foothold in the industry
Global Health Issues
Stay informed about global health issues, as they can significantly impact the demand for healthcare services and pharmaceuticals, influencing the performance of pharma stocks.

How to start investing in Pharma Stocks with INDmoney?

To buy Invest in Pharma Stocks from INDmoney, you will need to open a Demat account with them. Once you have opened a Demat account, you can follow these steps to buy Invest in Pharma Stocks:

Step 1
Complete KYC Process
Step 2
Invest in Pharma Stocks
Step 3
Choose for Intraday/Position

Should you invest in Invest in Pharma Stocks?

Investing in Pharma Stocks is prudent for those seeking stability, innovation, and exposure to a sector vital for global health. Evaluate your risk tolerance and embrace the potential for long-term growth in this resilient and dynamic landscape of pharmaceutical advancements.

Quick 5 Mins Course on Stock Market

Frequently Asked Questions

Healthcare stocks represent shares in companies within the healthcare sector, encompassing pharmaceuticals, biotechnology, medical services, and more.

Examine financial reports, including revenue, profit margins, and debt levels, to evaluate the financial stability of healthcare stocks.

Yes, healthcare stocks are often considered defensive due to the consistent demand for healthcare services, providing stability during economic downturns.

Regulatory changes can significantly affect healthcare stocks, influencing operations and financial performance. Staying informed about regulatory shifts is crucial.

Innovation is pivotal. Companies at the forefront of medical advancements and innovative solutions often present attractive investment opportunities in healthcare stocks.

Explore Stocks Category: